Healius to sell off Lumus imaging business

2 minute read


The provider confirmed on Monday it would refocus investment towards its pathology and clinical trials division in a bid to recover its losses.


The provider confirmed on Monday it would refocus investment towards its pathology and clinical trials division in a bid to recover its losses.

This content is for Health Services Daily subscribers only.
or Join Now.

End of content

No more pages to load

Log In Register ×